From multi-omics approaches to precision medicine in amyotrophic lateral sclerosis

G Morello, S Salomone, V D'Agata… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disorder,
caused by the degeneration of upper and lower motor neurons for which there is no truly …

Multiomics technologies: role in disease biomarker discoveries and therapeutics

MA Dar, A Arafah, KA Bhat, A Khan… - Briefings in …, 2023 - academic.oup.com
Medical research has been revolutionized after the publication of the full human genome.
This was the major landmark that paved the way for understanding the biological functions …

Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data

H Marriott, R Kabiljo, GP Hunt, AA Khleifat… - Acta neuropathologica …, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) displays considerable clinical and genetic
heterogeneity. Machine learning approaches have previously been utilised for patient …

Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases

V La Cognata, G Morello, S Cavallaro - International Journal of Molecular …, 2021 - mdpi.com
Molecular and clinical heterogeneity is increasingly recognized as a common characteristic
of neurodegenerative diseases (NDs), such as Alzheimer's disease, Parkinson's disease …

Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS

G Morello, M Guarnaccia, AG Spampinato… - Scientific reports, 2019 - nature.com
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal neurodegenerative disease.
Increasing the chances of success for future clinical strategies requires more in-depth …

Histaminergic transmission slows progression of amyotrophic lateral sclerosis

S Apolloni, S Amadio, P Fabbrizio… - Journal of cachexia …, 2019 - Wiley Online Library
Background Histamine is an immune modulator, neuroprotective, and remyelinating agent,
beneficially acting on skeletal muscles and promoting anti‐inflammatory features in …

Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression

IS Tarr, EP McCann, B Benyamin, TJ Peters… - Scientific reports, 2019 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by
the loss of upper and lower motor neurons. ALS exhibits high phenotypic variability …

Differential vulnerability of oculomotor versus hypoglossal nucleus during ALS: involvement of PACAP

G Maugeri, AG D'Amico, G Morello, D Reglodi… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive multifactorial disease characterized by
the loss of motor neurons (MNs). Not all MNs undergo degeneration: neurons of the …

[HTML][HTML] Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS

I Dervishi, O Gozutok, K Murnan, M Gautam, D Heller… - Scientific reports, 2018 - nature.com
Developing effective treatment strategies for neurodegenerative diseases require an
understanding of the underlying cellular pathways that lead to neuronal vulnerability and …

Splicing players are differently expressed in sporadic amyotrophic lateral sclerosis molecular clusters and brain regions

V La Cognata, G Gentile, E Aronica, S Cavallaro - Cells, 2020 - mdpi.com
Splicing is a tightly orchestrated process by which the brain produces protein diversity over
time and space. While this process specializes and diversifies neurons, its deregulation may …